Clinical Trial Update: Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety and tolerability of MRZ-99030 Eye Drops in healthy volunteers and glaucoma patients. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• MRZ-99030 Eye Drops

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Healthy Volunteers and Glaucoma Patients | Phase 1 | Status: COMPLETED